Aug 2 (Reuters) - Major global firms ranging from banks to chipmakers
are taking a largely cautious stance on their China business amid a frail
recovery at the world's second-largest economy from a pandemic slowdown.
    Following are comments from some of the top firms on their China business
during the latest reporting season:
 Company            Commentary 
 Haleon             The Sensodyne maker said sales from Fenbid pain reliever gel
                    doubled in China in the first half.
 Starbucks          The coffeehouse chain saw a sharp recovery in China, with
                    third-quarter comparable sales surging 46%.
 Merck & Co         The drugmaker said use of Gardasil in China was the biggest
                    growth driver for the human papillomavirus vaccine.
 Marriott           The U.S. hotel operator said rebounding demand in China
 International      boosted its earnings. 
 Toyota             The automaker said foreign exchange rate fluctuations and
                    its response to price cuts in China hurt its results there.
 Panasonic          The battery supplier said it saw no sign of a full-fledged
                    recovery in the factory automation sector in China, and that
                    it would take more time for areas such as servers, data
                    centres and ICT to recover overall.
 Procter & Gamble   The Tide detergent maker reported a 1% drop in its
                    fourth-quarter volumes, mainly due to weaker demand in the
                    Greater China region.  
 Intel              "The China market, I think, has been well reported, hasn't
                    come back as strongly as people would have expected
                    overall," chipmaker Intel CEO Pat Gelsinger said.
 Volkswagen         The German carmaker cut its full-year sales target after
                    sales dipped in China, its top market.
 AbbVie Inc         The Botox maker said it has seen rates for aesthetics
                    treatments in China fully recover to pre-COVID levels and
                    continues to anticipate strong growth through the rest of
                    the year in the country.
 Mastercard         Inbound cross-border travel to China stood at nearly 50% of
                    2019 levels, while outbound travel was nearly 70%, the
                    company said.
 Anglo American     The global miner said it has been surprised by how slow the
                    reopening of China has been but believed a recovery was
 L'Oreal            The Chinese market is "really picking up," although "not at
                    the speed everybody had hoped for," L'Oreal CEO Nicolas
                    Hieronimus told Reuters. 
 Mobileye Global                Saw weak demand for its driver-assistance
                    technology in China. 
 Rio Tinto          The world's biggest iron ore producer struck a cautiously
                    optimistic tone on China as the government has pledged more
                    policies to boost growth.
 Nissan             CEO Makoto Uchida said China sales outlook for the automaker
                    was now falling far below production capacity.
 Coca-Cola          The company saw strong demand for some juice business in
                    China but also flagged destocking activity in the second
 LG Energy          The company warned it faces weaker EV demand in China than
 Solution           previously expected.  
 Thermo Fisher      The company witnessed significantly slower economic activity
 Scientific         in China during the second quarter. "We think it's
                    appropriate to assume that this condition remains in place
                    for the remainder of the year," said CFO Stephen Williamson.
 Visa               "Looking at Mainland China specifically, cross-border travel
                    continued to improve but remains well below 2019 levels,"
                    CFO Vasant Prabhu said.
 LVMH               The French luxury giant logged a strong rebound in China
                    during the second quarter.
 3M Co              The industrial conglomerate flagged continued weak appetite
                    for consumer electronics demand in China.
 GE Healthcare      The company saw improved demand for medical equipment in the
                    region in the recent quarter and that is expected to
                    continue as China prioritizes improved healthcare access
                    following the end of the pandemic.  
 Dow Inc            The chemical maker said the anticipated rebound following
                    the end of pandemic curbs has yet to fully materialize.
 EssilorLuxottica   The luxury eyewear maker continued to benefit from a
                    recovery in China during the second quarter. 
 NXP                The chipmaker said China's export curbs on certain gallium
 Semiconductors     and germanium products did not impact the company.
 ABB                The engineering firm witnessed fewer new orders from China
                    in the quarter and said some customers were shifting
                    investments to other parts of Asia due to geopolitical
 Citigroup          The lender called it the "biggest disappointment" as growth
                    decelerated after an initial post-reopening pop.  
 (Reporting by Savyata Mishra and Arunima Kumar in Bengaluru; Additional
reporting by Niket Nishant, Granth Vanaik, Aditya Soni and Bhanvi Satija;
Editing by Sriraj Kalluvila, Eileen Soreng, Maju Samuel and Shinjini Ganguli)